• Skip to primary navigation
  • Skip to content
  • Skip to footer
Genelex Logo

Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
    • Patient Stories
  • Providers
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • News
    • Contact Us
  • Log In

News

White House 2016 Precision Medicine Initiative Summit – Recap

Genelex Blog White House 2016 Precision Medicine Initiative Summit – Recap In January 2015, President Obama announced the Precision Medicine Initiative, or PMI. The PMI was originally portioned $215 million in the 2016 budget, with the aim to use patient volunteered data on a massive scale

assortment-pills

U.S. VA Awards Genelex Contract to Reduce Veterans’ Healthcare Costs

Genelex Blog U.S. VA Awards Genelex Contract to Reduce Veterans’ Healthcare Costs The U.S. Department of Veterans Affairs has awarded a Federal Supply Schedule contract to Genelex as a government supplier, which took effect March 15th, 2016. The contract makes pharmacogenetic testing

Precision Trials Challenge

Genelex Blog Precision Trials Challenge Big thanks to Ranjit who submitted to this challenge with little notice, description is below. Comments from the online community will also be used as judging criteria. So any responses via comments/applause/views via the link below with respect to

United States Department of Veterans Affairs Awards Genelex Federal Supply Schedule Contract

Genelex Blog United States Department of Veterans Affairs Awards Genelex Federal Supply Schedule Contract Pharmacogenetic testing now available to improve complex medication management for veterans at risk of avoidable hospitalizations and ER visits Seattle, WA—March 15, 2016 – Genelex, the

Visit Genelex this week at HIMSS16 in Las Vegas

Genelex Blog Visit Genelex this week at HIMSS16 in Las Vegas Visit Genelex this week at HIMSS16 in Las Vegas and see why we’re in the headlines: HIMSS Honoree explains why you won’t want to miss Genelex at the conference: “This is a real, practical application of precision medicine that

An Alternative to the Hype of the HIMSS16 Show Floor

Genelex Blog An Alternative to the Hype of the HIMSS16 Show Floor Dave Garets, Healthcare IT industry analyst I know what you’re thinking: “Garets is mouthing off again. Thank goodness he doesn’t do it more than once a year.” Last year about this time I blogged about what you’d see at

Oxycodone Toxicity

Genelex Blog Oxycodone Toxicity On April 7, 2015 we blogged about a young boy who became comatose after receiving tramadol for post-tonsillectomy pain treatment. It was later learned that the boy was a CYP2D6 ultra rapid metabolizer. Then on July 21, 2015, we blogged about the risks of

medicine

Tamoxifen and CYP2D6 Interactions

Genelex Blog Tamoxifen and CYP2D6 Interactions CYP2D6 gene testing for personalizing tamoxifen therapy has been a source of confusion and debate for over a decade. In addition to conflicting outcomes data on breast cancer recurrence rates in women with deficient CYP2D6 enzyme activity (i.e.,

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 15
  • Next Page »

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
Resources
FAQs

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Testimonials

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.

© GENELEX 2019 ・ PRIVACY POLICY ・ REFERENCES ・ CAP LAB 4344001 ・CLIA 50D0980559 ・NYDOH PFI 8201